Cambridge Nutritional Sciences plc (AIM:CNSL)
London · Delayed Price · Currency is GBP · Price in GBX 2.075
-0.075 (-3.48%)
May 8, 2026, 3:15 PM GMT
AIM:CNSL Market Cap
AIM:CNSL has a market cap or net worth of 5.12 million as of May 8, 2026. Its market cap has decreased by -20.37% in one year.
Market Cap
5.12M
Enterprise Value
1.76M
Revenue
8.06M
Ranking
n/a
PE Ratio
3.75
Stock Price
2.08
Market Cap Chart
Since December 7, 2007, AIM:CNSL's market cap has increased from 3.12M to 5.12M, an increase of 63.77%. That is a compound annual growth rate of 2.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 5.12M | 10.26% |
| Dec 31, 2025 | 4.64M | -29.09% |
| Dec 31, 2024 | 6.54M | 14.71% |
| Dec 29, 2023 | 5.70M | -36.00% |
| Dec 30, 2022 | 8.91M | -82.10% |
| Dec 31, 2021 | 49.78M | -57.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.41B |
| GSK plc | 74.85B |
| Haleon | 29.72B |
| Smith & Nephew | 9.54B |
| CRISM Therapeutics | 6.21M |
| Proteome Sciences | 5.72M |
| OptiBiotix Health | 5.27M |
| Thalia Therapeutics | 4.79M |